Avoid EU Mistakes And Cast Regulatory Net Wide Globally, UK Told
Executive Summary
When it comes to the future UK medtech regulations, the pendulum is swinging between pessimism and dismay, to optimism and opportunity, in the words of ABHI’s Phil Brown. Where will it settle, what can the UK learn from the EU, and will global initiatives make it into the UK arsenal?
You may also be interested in...
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.
Non-Medical Brain Stimulation Devices: Could They Be Down-Classified Again In the EU?
Six types of products that do not have an intended medical purpose fall under the scope of the Medical Device Regulation. Understanding their risks is complex and subject to regular re-examination by the European Commission.